Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 24, 2008

View Archived Issues

Promising phase II results seen with tosedostat in elderly acute myeloid leukemia patients

Data on antimalarial vaccine, AdCh63 ME-TRAP, disclosed at the ASTMH Annual Meeting

Recent studies on safety of IC-51 Japanese encephalitis vaccine reported

Interim safety analysis reported for Panvac vaccine in metastatic breast cancer patients

Recent Pfizer patent reports new treatments for neurodegenerative disorders

Wyeth Pharmaceuticals discloses new agents for asthma and other disorders in recent patent

Recent Takeda patent imparts novel agents for lipoprotein disorders

Mologen receives grant from European Commission to develop leishmaniasis vaccine

AstraZeneca submits sNDA for Nexium for GERD treatment in infants

GSK initiates phase III program for novel cardiovascular medication, darapladib

Neuralstem files IND application with FDA for first ALS stem cell trial

Memory commences phase IIa MEM-1414 trial in asthma

Baxter receives EMEA positive opinion for cell culture-based pandemic flu vaccine

CHMP grants positive opinion for prasugrel for atherothrombotic events

CrystalGenomics presents positive phase IIa results for CG-100649 in OA

Daiichi Sankyo launches Haemophilus influenzae type b vaccine

Emergent BioSolutions receives FDA approval for BioThrax sBLA

AstraZeneca and MAP sign agreement for Unit Dose Budesonide for pediatric asthma

CHMP recommends granting marketing authorization to Ferring's Firmagon for prostate cancer

Intanza/IDflu vaccine receives positive opinion from CHMP

Amgen submits BLA to FDA for RANK ligand inhibitor denosumab for PMO and osteopenia

King submits NDA to FDA for imaging agent CorVue

La Jolla provides update on ongoing Riquent phase III lupus trial

Miglustat receives positive opinion from CHMP for Niemann-Pick type C disease

Naproxcinod shows differentiated 24-hour blood pressure profile after 13 weeks

Otsuka describes new treatment options for tuberculosis in a recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...